SCHEMBL7685504

SCHEMBL7685504

Cc1ccnc2c1C(=O)CC(c1cccc(Cl)c1Cl)C2

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP1LC3B Q9GZQ8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6797519 0.90 TP53 (0.47)
SCHEMBL7683993 0.86 MAP1LC3B (0.40) MAP1LC3B
Hydrochloric Acid SCHEMBL7678966 0.85
SCHEMBL7683162 0.83 HSP90AA1 (0.42)
SCHEMBL7682930 0.82 MAPT (0.44)
SCHEMBL7687703 0.80
SCHEMBL7685259 0.80 MAP1LC3B (0.43) MAP1LC3B
SCHEMBL7689633 0.80 MAP1LC3B (0.51) MAP1LC3B
SCHEMBL7680811 0.80
SCHEMBL7683538 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350749-B1 SODIUM CHANNEL MODULATORS, ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS, ANGINA PECTORIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-02-26 US disclosed
EP-1057812-A1 AMINOGUANIDINE HYDRAZONE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND DRUGS THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-12-06 EP disclosed